Cargando…

Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls

Naturally occurring autoantibodies (NAbs) against a number of potentially disease-associated cellular proteins, including Amyloid-beta(1–42) (Abeta(1–42)), Alpha-synuclein (Asyn), myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG), and S100 calcium binding protein B (S100B) have b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maetzler, Walter, Apel, Anja, Langkamp, Markus, Deuschle, Christian, Dilger, Sarah Selina, Stirnkorb, Johannes Georg, Schulte, Claudia, Schleicher, Erwin, Gasser, Thomas, Berg, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931625/ https://www.ncbi.nlm.nih.gov/pubmed/24586351 http://dx.doi.org/10.1371/journal.pone.0088604

Ejemplares similares

Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
por: Heinzel, Sebastian, et al.
Publicado: (2014)

Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
por: Bernhard, Felix P., et al.
Publicado: (2016)

Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
por: Mielke, Michelle M., et al.
Publicado: (2013)

Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
por: Maetzler, Walter, et al.
Publicado: (2012)

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
por: Maetzler, Walter, et al.
Publicado: (2016)

Dual-Task Performance in GBA Parkinson's Disease
por: Srulijes, Karin, et al.
Publicado: (2017)

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
por: Stoessel, Daniel, et al.
Publicado: (2018)

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease
por: Yilmaz, Rezzak, et al.
Publicado: (2018)

Inflammatory profile in LRRK2-associated prodromal and clinical PD
por: Brockmann, Kathrin, et al.
Publicado: (2016)

Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
por: Gschmack, Eva, et al.
Publicado: (2022)

Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study
por: Becker, Sara, et al.
Publicado: (2022)

Instrumented Functional Reach Test Differentiates Individuals at High Risk for Parkinson’s Disease from Controls
por: Hasmann, Sandra E., et al.
Publicado: (2014)

Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
por: Hobert, Markus A., et al.
Publicado: (2019)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
por: Deleidi, Michela, et al.
Publicado: (2012)

Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson’s Disease
por: Alzaid, Haidar, et al.
Publicado: (2020)

Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
por: Maetzler, Walter, et al.
Publicado: (2015)

Impaired Trunk Stability in Individuals at High Risk for Parkinson's Disease
por: Maetzler, Walter, et al.
Publicado: (2012)

Effect of Fear of Falling on Turning Performance in Parkinson’s Disease in the Lab and at Home
por: Haertner, Linda, et al.
Publicado: (2018)

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
por: Gerlach, Manfred, et al.
Publicado: (2011)

Post-Cueing Deficits with Maintained Cueing Benefits in Patients with Parkinson’s Disease Dementia
por: Gräber, Susanne, et al.
Publicado: (2014)

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis
por: Margraf, Nils G., et al.
Publicado: (2022)

Genetic basis of Parkinson’s disease: inheritance, penetrance, and expression
por: Schulte, Claudia, et al.
Publicado: (2011)

The Power of Musification: Sensor‐Based Music Feedback Improves Arm Swing in Parkinson's Disease
por: Mainka, Stefan, et al.
Publicado: (2021)

In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
por: Santoro, Matteo, et al.
Publicado: (2016)

S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
por: Sathe, Kinnari, et al.
Publicado: (2012)

What is Functional Mobility Applied to Parkinson’s Disease?
por: Bouça-Machado, Raquel, et al.
Publicado: (2018)

Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
por: Borsche, Max, et al.
Publicado: (2020)

Gait analysis with wearables predicts conversion to Parkinson disease
por: Del Din, Silvia, et al.
Publicado: (2019)

Step Length Is a Promising Progression Marker in Parkinson’s Disease
por: Welzel, Julius, et al.
Publicado: (2021)

Moderate Frequency Resistance and Balance Training Do Not Improve Freezing of Gait in Parkinson's Disease: A Pilot Study
por: Schlenstedt, Christian, et al.
Publicado: (2018)

Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking
por: Elshehabi, Morad, et al.
Publicado: (2016)

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
por: Hopfner, Franziska, et al.
Publicado: (2019)

Cholinergic Pathway SNPs and Postural Control in 477 Older Adults
por: Arnold, Carina, et al.
Publicado: (2018)

Influence of Different Cut-Off Values on the Diagnosis of Mild Cognitive Impairment in Parkinson's Disease
por: Liepelt-Scarfone, Inga, et al.
Publicado: (2011)

Effect of Fear of Falling on Mobility Measured During Lab and Daily Activity Assessments in Parkinson’s Disease
por: Atrsaei, Arash, et al.
Publicado: (2021)

Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson’s Disease
por: Tkaczynska, Zuzanna, et al.
Publicado: (2020)

Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?
por: Heinzel, Sebastian, et al.
Publicado: (2018)

How Mobile Health Technology and Electronic Health Records Will Change Care of Patients with Parkinson’s Disease
por: Hansen, Clint, et al.
Publicado: (2018)

Autoantibody-dependent amplification of inflammation in SLE
por: Lou, Hantao, et al.
Publicado: (2020)

Cognitive parameters can predict change of walking performance in advanced Parkinson’s disease – Chances and limits of early rehabilitation
por: Geritz, Johanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ln30851petroe9ncs1kofuufcl